Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Users Online: 419 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
This article has been cited by
1Testing Tuberculosis Drug Efficacy in a Zebrafish High-Throughput Translational Medicine Screen
Anita Ordas,Robert-Jan Raterink,Fraser Cunningham,Hans J. Jansen,Malgorzata I. Wiweger,Susanne Jong-Raadsen,Sabine Bos,Robert H. Bates,David Barros,Annemarie H. Meijer,Rob J. Vreeken,Lluís Ballell-Pages,Ron P. Dirks,Thomas Hankemeier,Herman P. Spaink
Antimicrobial Agents and Chemotherapy.2015;59(2)753
[DOI]
2Design, synthesis and biological evaluation of novel quinoline-based carboxylic hydrazides as anti-tubercular agents
Subhash Chander,Penta Ashok,Davie Cappoen,Paul Cos,Sankaranarayanan Murugesan
Chemical Biology & Drug Design.2016;88(4)585
[DOI]
3Viability, morphology, and proteome of Mycobacterium smegmatis MSMEG_0319 knockout strain
Shanshan Sha,Xiaoxia Shi,Liming Xu,Jiabin Wen,Yi Xin,Yufang Ma
PROTEOMICS.2016;16(7)1090
[DOI]
4Dual inhibition of the terminal oxidases eradicates antibiotic-tolerant Mycobacterium tuberculosis
Bei Shi Lee,Kiel Hards,Curtis A Engelhart,Erik J Hasenoehrl,Nitin P Kalia,Jared S Mackenzie,Ekaterina Sviriaeva,Shi Min Sherilyn Chong,Malathy Sony S Manimekalai,Vanessa H Koh,John Chan,Jiayong Xu,Sylvie Alonso,Marvin J Miller,Adrie J C Steyn,Gerhard Grüber,Dirk Schnappinger,Michael Berney,Gregory M Cook,Garrett C Moraski,Kevin Pethe
EMBO Molecular Medicine.2021;13(1)1090
[DOI]
5Anything to Stay Alive: The Challenges of a Campaign for an Experimental Drug
Nathan Geffen
Developing World Bioethics.2016;16(1)45
[DOI]
6Development of acridine derivatives as selective Mycobacterium tuberculosis DNA gyrase inhibitors
Brahmam Medapi,Nikhila Meda,Pushkar Kulkarni,Perumal Yogeeswari,Dharmarajan Sriram
Bioorganic & Medicinal Chemistry.2016;24(4)877
[DOI]
7Scientific rationale for traditional use of plants to treat tuberculosis in the eastern region of the OR Tambo district, South Africa
B. Madikizela,L.J. McGaw
Journal of Ethnopharmacology.2018;224(4)250
[DOI]
8The structure-based virtual screening of non-benzofuran inhibitors against M. tuberculosis Pks13-TE for anti-tuberculosis phenotypic discovery
Guode Zhao,Xirong Tian,Jian Wang,Maosheng Cheng,Tianyu Zhang,Zihou Wang
New Journal of Chemistry.2021;45(3)1286
[DOI]
9Current advances in the clinical development of anti-tubercular agents
Samanvai Reddy Tetali,Eswar Kunapaeddi,Raghu Prasad Mailavaram,Vinayak Singh,Pobitra Borah,Pran Kishore Deb,Katharigatta N. Venugopala,Wafa Hourani,Rakesh Kumar Tekade
Tuberculosis.2020;125(3)101989
[DOI]
10Identification and characterization of aspartyl-tRNA synthetase inhibitors against Mycobacterium tuberculosis by an integrated whole-cell target-based approach
Ramón Soto,Esther Perez-Herran,Beatriz Rodriguez,Bogdan M. Duma,Monica Cacho-Izquierdo,Alfonso Mendoza-Losana,Joel Lelievre,David Barros Aguirre,Lluis Ballell,Liam R. Cox,Luke J. Alderwick,Gurdyal S. Besra
Scientific Reports.2018;8(1)101989
[DOI]
11Benzo[ a ]phenazine derivatives: Promising scaffolds to combat resistant Mycobacterium tuberculosis
Priscila Cristina Bartolomeu Halicki,Eufrânio Nunes Silva,Guilherme Augusto de Melo Jardim,Renata Gomes de Almeida,Juliano Rosa de Menezes Vicenti,Bruna Lisboa Gonçalves,Pedro Eduardo Almeida Silva,Daniela Fernandes Ramos
Chemical Biology & Drug Design.2021;98(3)352
[DOI]
12Antituberculosis Drug Interactions with Membranes: A Biophysical Approach Applied to Bedaquiline
Marina Pinheiro,Heinz Amenitsch,Salette Reis
Membranes.2019;9(11)141
[DOI]
13Synthesis and bioactivity of novel triazole incorporated benzothiazinone derivatives as antitubercular and antioxidant agent
Mubarak H. Shaikh,Dnyaneshwar D. Subhedar,Manisha Arkile,Vijay M. Khedkar,Nandadeep Jadhav,Dhiman Sarkar,Bapurao B. Shingate
Bioorganic & Medicinal Chemistry Letters.2016;26(2)561
[DOI]
14Cell wall peptidoglycan in Mycobacterium tuberculosis: An Achilles’ heel for the TB-causing pathogen
Arundhati Maitra,Tulika Munshi,Jess Healy,Liam T Martin,Waldemar Vollmer,Nicholas H Keep,Sanjib Bhakta
FEMS Microbiology Reviews.2019;43(5)548
[DOI]
15Synthesis and Structure–Activity Relationship Studies of C2-Modified Analogs of the Antimycobacterial Natural Product Pyridomycin
Maryline Kienle,Patrick Eisenring,Barbara Stoessel,Oliver P. Horlacher,Samuel Hasler,Gwénaëlle van Colen,Ruben C. Hartkoorn,Anthony Vocat,Stewart T. Cole,Karl-Heinz Altmann
Journal of Medicinal Chemistry.2020;63(3)1105
[DOI]
16The cost-effectiveness of a bedaquiline-containing short-course regimen for the treatment of multidrug-resistant tuberculosis in South Africa
Abela Mpobela Agnarson,Abeda Williams,Chrispin Kambili,Gunnar Mattson,Laurent Metz
Expert Review of Anti-infective Therapy.2020;18(5)475
[DOI]
17Current perspectives in drug discovery against tuberculosis from natural products
Joseph Mwanzia Nguta,Regina Appiah-Opong,Alexander K. Nyarko,Dorothy Yeboah-Manu,Phyllis G.A. Addo
International Journal of Mycobacteriology.2015;4(3)165
[DOI]
18Genomic Insight into Mechanisms of Reversion of Antibiotic Resistance in Multidrug Resistant Mycobacterium tuberculosis Induced by a Nanomolecular Iodine-Containing Complex FS-1
Aleksandr I. Ilin,Murat E. Kulmanov,Ilya S. Korotetskiy,Rinat A. Islamov,Gulshara K. Akhmetova,Marina V. Lankina,Oleg N. Reva
Frontiers in Cellular and Infection Microbiology.2017;7(3)165
[DOI]
19Synthesis and antitubercular and antibacterial activity of some active fluorine containing quinoline–pyrazole hybrid derivatives
Nagabhushana Nayak,Jurupula Ramprasad,Udayakumar Dalimba
Journal of Fluorine Chemistry.2016;183(3)59
[DOI]
20Design, Synthesis, and in vitro antitubercular activity of 1,2,3-triazolyl-dihydroquinoline derivatives
Saleha Banu,Rajitha Bollu,Lingaiah Nagarapu,Jagadeesh Babu Nanubolu,Perumal Yogeswari,Dharmarajan Sriram,Shravan Kumar Gunda,Divyasphoorthi Vardhan
Chemical Biology & Drug Design.2018;92(1)1315
[DOI]
21Emerging drugs and alternative possibilities in the treatment of tuberculosis
S. Hofman,M.M. Segers,S. Ghimire,M.S. Bolhuis,M.G.G. Sturkenboom,D. Van Soolingen,J.W.C. Alffenaar
Expert Opinion on Emerging Drugs.2016;21(1)103
[DOI]
22Design, Synthesis and Biological Evaluation of Anti-tuberculosis Agents based on Bedaquiline Structure
Chengjun Wu,Jinghan Luo,Mengtong Wu,Fanzhen Meng,Zhiqiang Cai,Yu Chen,Tiemin Sun
Medicinal Chemistry.2020;16(5)703
[DOI]
23Design, Synthesis and Biological Evaluation of Anti-tuberculosis Agents based on Bedaquiline Structure
Yaser Mohammed Al-Worafi
Medicinal Chemistry.2020;16(5)87
[DOI]
24TB Summit 2014
Arundhati Maitra,Sanjib Bhakta
Virulence.2014;5(5)638
[DOI]
25Bedaquiline- versus injectable-containing drug-resistant tuberculosis regimens: a cost-effectiveness analysis
Ana-Maria Ionescu,Abela Mpobela Agnarson,Chrispin Kambili,Laurent Metz,Jonathan Kfoury,Steven Wang,Abeda Williams,Vikram Singh,Adrian Thomas
Expert Review of Pharmacoeconomics & Outcomes Research.2018;18(6)677
[DOI]
26Synthesis, molecular docking, antimycobacterial and antimicrobial evaluation of new pyrrolo[3,2- c ]pyridine Mannich bases
Gilish Jose,Tholappanavara H. Suresha Kumara,Haliwana B.V. Sowmya,Dharmarajan Sriram,Tayur N. Guru Row,Amar A. Hosamani,Sunil S. More,Bhavya Janardhan,B.G. Harish,Sandeep Telkar,Yalegara Siddappa Ravikumar
European Journal of Medicinal Chemistry.2017;131(6)275
[DOI]
27Monocarbonyl curcuminoids as antituberculosis agents with their moderate in-vitro metabolic stability on human liver microsomes
Yalegara Siddappa Gagandeep,Manisha Singh,Saqib Kidawi,Ujjalkumar S. Das,Thirumurthy Velpandian,Ramandeep Singh,Diwan S. Rawat
Journal of Biochemical and Molecular Toxicology.2021;35(6)1
[DOI]
28Novel isoniazid–amidoether derivatives: synthesis, characterization and antimycobacterial activity evaluation
Deepak Kumar,Garima Khare,Beena Beena,Saqib Kidwai,Anil K. Tyagi,Ramandeep Singh,Diwan S. Rawat
MedChemComm.2015;6(1)131
[DOI]
29Novel isoniazid–amidoether derivatives: synthesis, characterization and antimycobacterial activity evaluation
Lawrence M. Friedman,Curt D. Furberg,David L. DeMets,David M. Reboussin,Christopher B. Granger
MedChemComm.2015;6(1)519
[DOI]
30Inhibition of the ATP synthase sensitizes Staphylococcus aureus towards human antimicrobial peptides
Liping Liu,Christian Beck,Katrine Nøhr-Meldgaard,Andreas Peschel,Dorothee Kretschmer,Hanne Ingmer,Martin Vestergaard
Scientific Reports.2020;10(1)519
[DOI]
31Synthesis, biological evaluation, and molecular docking studies of novel 3-aryl-5-(alkyl-thio)-1H-1,2,4-triazoles derivatives targetingMycobacterium tuberculosis
Navnath D. Rode,Amol D. Sonawane,Laxman Nawale,Vijay M. Khedkar,Ramesh A. Joshi,Anjali P. Likhite,Dhiman Sarkar,Rohini R. Joshi
Chemical Biology & Drug Design.2017;90(6)1206
[DOI]
32Mycobacterial protein tyrosine kinase, PtkA phosphorylates PtpA at tyrosine residues and the mechanism is stalled by the novel series of inhibitors
Swati Jaiswal,Aditi Chatterjee,Sapna Pandey,Kiran Lata,Ranjith Kumar Gadi,Rajesh Manda,Sanjay Kumar,Maddi Sridhar Reddy,Ravishankar Ramachandran,Kishore K. Srivastava
Journal of Drug Targeting.2019;27(1)51
[DOI]
33Is PF-00835231 a Pan-SARS-CoV-2 Mpro Inhibitor? A Comparative Study
Mohammad Hassan Baig,Tanuj Sharma,Irfan Ahmad,Mohammed Abohashrh,Mohammad Mahtab Alam,Jae-June Dong
Molecules.2021;26(6)1678
[DOI]
34One Step Forward: Successful End-of-Treatment Outcomes of Patients With Drug-Resistant Tuberculosis Who Received Concomitant Bedaquiline and Delamanid in Mumbai, India
Mrinalini Das,Alpa Dalal,Chinmay Laxmeshwar,Shilpa Ravi,Fatima Mamnoon,Augusto C Meneguim,Roma Paryani,Taanya Mathur,Pramila Singh,Homa Mansoor,Stobdan Kalon,Farah Naz Hossain,Nathalie Lachenal,Sylvine Coutisson,Gabriella Ferlazzo,Petros Isaakidis
Clinical Infectious Diseases.2021;73(9)e3496
[DOI]
35Novel thiomorpholine tethered isatin hydrazones as potential inhibitors of resistant Mycobacterium tuberculosis
Sivanandhan Karunanidhi,Balakumar Chandrasekaran,Rajshekhar Karpoormath,Harun M. Patel,Francis Kayamba,Srinivas Reddy Merugu,Vishal Kumar,Sanjeev Dhawan,Babita Kushwaha,Mavela Cleopus Mahlalela
Bioorganic Chemistry.2021;115(9)105133
[DOI]
36Cell Wall Proteomics Reveal Phenotypic Adaption of Drug-Resistant Mycobacterium smegmatis to Subinhibitory Rifampicin Exposure
Alexander D. Giddey,Tariq A. Ganief,Naadir Ganief,Anastasia Koch,Digby F. Warner,Nelson C. Soares,Jonathan M. Blackburn
Frontiers in Medicine.2021;8(9)105133
[DOI]
37Plasticity of the Mycobacterium tuberculosis respiratory chain and its impact on tuberculosis drug development
Tiago Beites,Kathryn O’Brien,Divya Tiwari,Curtis A. Engelhart,Shaun Walters,Jenna Andrews,Hee-Jeong Yang,Michelle L. Sutphen,Danielle M. Weiner,Emmanuel K. Dayao,Matthew Zimmerman,Brendan Prideaux,Prashant V. Desai,Thierry Masquelin,Laura E. Via,Véronique Dartois,Helena I. Boshoff,Clifton E. Barry,Sabine Ehrt,Dirk Schnappinger
Nature Communications.2019;10(1)105133
[DOI]
38In vitro activity of collinin isolated from the leaves of Zanthoxylum schinifolium against multidrug- and extensively drug-resistant Mycobacterium tuberculosis
Sukyung Kim,Hoonhee Seo,Hafij Al Mahmud,Md Imtiazul Islam,Byung-Eui Lee,Myoung-Lae Cho,Ho-Yeon Song
Phytomedicine.2018;46(1)104
[DOI]
39Tuberculosis: Still a Way to go ahead for a Lead- A Review
Priyanka Bose,Amit K Harit,Kamal Krishna Halder
Journal of Analytical & Pharmaceutical Research.2017;5(6)104
[DOI]
40Evaluating Integrated Care for People Living With HIV and Multidrug-Resistant Tuberculosis in South Africa: A Case-Based Approach Using the Chronic Care Model
Keri Geiger,Alanna Bergman,Jason E. Farley
Journal of the Association of Nurses in AIDS Care.2021;32(6)e91
[DOI]
41The pregnane X receptor in tuberculosis therapeutics
Amina I Shehu,Guangming Li,Wen Xie,Xiaochao Ma
Expert Opinion on Drug Metabolism & Toxicology.2016;12(1)21
[DOI]
42Successful bedaquiline-containing antimycobacterial treatment in post-traumatic skin and soft-tissue infection by Mycobacterium fortuitum complex: a case report
Johanna Erber,Simon Weidlich,Tristan Tschaikowsky,Kathrin Rothe,Roland M. Schmid,Jochen Schneider,Christoph D. Spinner
BMC Infectious Diseases.2020;20(1)21
[DOI]
43Effect of Disease State on the Pharmacokinetics of Bedaquiline in Renal-Impaired and Diabetic Rats
Abhishek Gour,Ashish Dogra,Sumit Sharma,Priya Wazir,Utpal Nandi
ACS Omega.2021;6(10)6934
[DOI]
44Whole-Cell Screening-Based Identification of Inhibitors against the Intraphagosomal Survival of Mycobacterium tuberculosis
Garima Khare,Praveen Kumar,Anil K. Tyagi
Antimicrobial Agents and Chemotherapy.2013;57(12)6372
[DOI]
45Emergence of nontuberculous mycobacteria infections during bedaquiline-containing regimens in multidrug-resistant tuberculosis patients
Jingtao Gao,Yi Pei,Xiaofeng Yan,Guomin Shi,Tongxin Li,Mengqiu Gao,Yuhong Liu,Yufeng Wang,Wei Shu,Liang Li,Yu Pang
International Journal of Infectious Diseases.2020;100(12)196
[DOI]
46Extensively Drug-resistant Tuberculosis (XDR-TB)-inhibitors to Overcome the Scourge of Drug-resistant Tuberculosis: a Perspective
Harun Patel,Iqrar Ahmad,Harsha Jadhav,Rahul Pawara,Anand Mundada,Matin Shaikh,Sanjay Surana
Reviews and Advances in Chemistry.2020;10(3-4)112
[DOI]
47Diagnosis and treatment of multidrug-resistant tuberculosis
Young Ae Kang
Journal of the Korean Medical Association.2014;57(1)27
[DOI]
48N-Benzyl-4-((heteroaryl)methyl)benzamides: A New Class of Direct NADH-Dependent 2-transEnoyl-Acyl Carrier Protein Reductase (InhA) Inhibitors with Antitubercular Activity
Ana Guardia,Gulcin Gulten,Raquel Fernandez,Jesus Gómez,Feng Wang,Maire Convery,Delia Blanco,María Martínez,Esther Pérez-Herrán,Marta Alonso,Fátima Ortega,Joaquín Rullás,David Calvo,Lydia Mata,Robert Young,James C. Sacchettini,Alfonso Mendoza-Losana,Modesto Remuiñán,Lluís Ballell Pages,Julia Castro-Pichel
ChemMedChem.2016;11(7)687
[DOI]
49Preliminary Results of Bedaquiline as Salvage Therapy for Patients With Nontuberculous Mycobacterial Lung Disease
Julie V. Philley,Richard J. Wallace,Jeana L. Benwill,Varsha Taskar,Barbara A. Brown-Elliott,Foram Thakkar,Timothy R. Aksamit,David E. Griffith
Chest.2015;148(2)499
[DOI]
50Total Synthesis and Conformational Study of Callyaerin A: Anti-Tubercular Cyclic Peptide Bearing a Rare Rigidifying (Z )-2,3- Diaminoacrylamide Moiety
Shengping Zhang,Luis M. De Leon Rodriguez,Ivanhoe K. H. Leung,Gregory M. Cook,Paul W. R. Harris,Margaret A. Brimble
Angewandte Chemie.2018;130(14)3693
[DOI]
51Antitubercular, Antimalarial Activity and Molecular Docking Study of New Synthesized 7-Chloroquinoline Derivatives
Ankit J. Patel,Manish P. Patel,Amitkumar B. Dholakia,Vishant C. Patel,Darshan S. Patel
Polycyclic Aromatic Compounds.2021;130(14)1
[DOI]
52Synthesis and evaluation of anti-tubercular activity of 6-(4-substitutedpiperazin-1-yl) phenanthridine analogues
Hunsur Nagendra Nagesh,Narva Suresh,Kalaga Mahalakshmi Naidu,Boyineni Arun,Jonnalagadda Padma Sridevi,Dharmarajan Sriram,Perumal Yogeeswari,Kondapalli Venkata Gowri Chandra Sekhar
European Journal of Medicinal Chemistry.2014;74(14)333
[DOI]
53Ultrasound Assisted Synthesis of 4-(Benzyloxy)-N-(3-chloro-2-(substitutedphenyl)-4-oxoazetidin-1-yl) Benzamide as Challenging Anti-Tubercular Scaffold
Urja Nimbalkar,Julio Seijas,Rachna Borkute,Manoj Damale,Jaiprakash Sangshetti,Dhiman Sarkar,Anna Nikalje
Molecules.2018;23(8)1945
[DOI]
54TBAJ-876 Displays Bedaquiline-Like Mycobactericidal Potency without Retaining the Parental Drug’s Uncoupler Activity
Jickky Palmae Sarathy,Priya Ragunathan,Christopher B. Cooper,Anna M. Upton,Gerhard Grüber,Thomas Dick
Antimicrobial Agents and Chemotherapy.2020;64(2)1945
[DOI]
55Design, synthesis and evaluation of 6-(4-((substituted-1H-1,2,3-triazol-4-yl)methyl)piperazin-1-yl)phenanthridine analogues as antimycobacterial agents
Hunsur Nagendra Nagesh,Kalaga Mahalakshmi Naidu,Damarla Harika Rao,Jonnalagadda Padma Sridevi,Dharmarajan Sriram,Perumal Yogeeswari,Kondapalli Venkata Gowri Chandra Sekhar
Bioorganic & Medicinal Chemistry Letters.2013;23(24)6805
[DOI]
56Tomatidine Is a Lead Antibiotic Molecule That Targets Staphylococcus aureus ATP Synthase Subunit C
Maxime Lamontagne Boulet,Charles Isabelle,Isabelle Guay,Eric Brouillette,Jean-Philippe Langlois,Pierre-Étienne Jacques,Sébastien Rodrigue,Ryszard Brzezinski,Pascale B. Beauregard,Kamal Bouarab,Kumaraswamy Boyapelly,Pierre-Luc Boudreault,Éric Marsault,François Malouin
Antimicrobial Agents and Chemotherapy.2018;62(6)6805
[DOI]
57Effect of Natural Phenolics on Pharmacokinetic Modulation of Bedaquiline in Rat to Assess the Likelihood of Potential Food–Drug Interaction
Pankul Kotwal,Ashish Dogra,Ankita Sharma,Shipra Bhatt,Abhishek Gour,Sumit Sharma,Priya Wazir,Parvinder Pal Singh,Ajay Kumar,Utpal Nandi
Journal of Agricultural and Food Chemistry.2020;68(5)1257
[DOI]
58In Vitro Susceptibility Testing of Bedaquiline against Mycobacterium avium Complex
Barbara A. Brown-Elliott,Julie V. Philley,David E. Griffith,Foram Thakkar,Richard J. Wallace
Antimicrobial Agents and Chemotherapy.2017;61(2)1257
[DOI]
59Benzothiazinone-piperazine derivatives as efficient Mycobacterium tuberculosis DNA gyrase inhibitors
Manoj Chandran,Janupally Renuka,Jonnalagadda Padma Sridevi,Ganesh S. Pedgaonkar,Vanaparthi Asmitha,Perumal Yogeeswari,Dharmarajan Sriram
International Journal of Mycobacteriology.2015;4(2)104
[DOI]
60Slow-Binding Inhibition of Mycobacterium tuberculosis Shikimate Kinase by Manzamine Alkaloids
Johayra Simithy,Ngolui Rene Fuanta,Mansour Alturki,Judith V. Hobrath,Amir E. Wahba,Ivett Pina,Jnanendra Rath,Mark T. Hamann,Jack DeRuiter,Douglas C. Goodwin,Angela I. Calderón
Biochemistry.2018;57(32)4923
[DOI]
61Crystal structure of Mycobacterium tuberculosis ketol-acid reductoisomerase at 1.0 Å resolution – a potential target for anti-tuberculosis drug discovery
You Lv,Ajit Kandale,Shun Jie Wun,Ross P. McGeary,Simon J. Williams,Bostjan Kobe,Volker Sieber,Mark A. Schembri,Gerhard Schenk,Luke W. Guddat
The FEBS Journal.2016;283(7)1184
[DOI]
62The Biotin Biosynthetic Pathway in Mycobacterium tuberculosis is a Validated Target for the Development of Antibacterial Agents
Matthew R. Bockman,Neeraj Mishra,Courtney C. Aldrich
Current Medicinal Chemistry.2020;27(25)4194
[DOI]
63Design, Synthesis, and Biological Evaluation of New 8-Trifluoromethylquinoline Containing Pyrazole-3-carboxamide Derivatives
Nagabhushana Nayak,Jurupula Ramprasad,Udayakumar Dalimba
Journal of Heterocyclic Chemistry.2017;54(1)171
[DOI]
64Substituted N-Phenyl-5-(2-(phenylamino)thiazol-4-yl)isoxazole-3-carboxamides Are Valuable Antitubercular Candidates that Evade Innate Efflux Machinery
Elisa Azzali,Diana Machado,Amit Kaushik,Federica Vacondio,Sara Flisi,Clotilde Silvia Cabassi,Gyanu Lamichhane,Miguel Viveiros,Gabriele Costantino,Marco Pieroni
Journal of Medicinal Chemistry.2017;60(16)7108
[DOI]
65Efflux pumps in Mycobacterium tuberculosis and their inhibition to tackle antimicrobial resistance
Mark Laws,Peiqin Jin,Khondaker Miraz Rahman
Trends in Microbiology.2021;60(16)7108
[DOI]
66Scaffold morphing leading to evolution of 2,4-diaminoquinolines and aminopyrazolopyrimidines as inhibitors of the ATP synthesis pathway
Subramanyam J. Tantry,Vikas Shinde,Gayathri Balakrishnan,Shankar D. Markad,Amit K. Gupta,Jyothi Bhat,Ashwini Narayan,Anandkumar Raichurkar,Lalit Kumar Jena,Sreevalli Sharma,Naveen Kumar,Robert Nanduri,Sowmya Bharath,Jitendar Reddy,Vijender Panduga,K. R. Prabhakar,Karthikeyan Kandaswamy,Parvinder Kaur,Neela Dinesh,Supreeth Guptha,Ramanatha Saralaya,Manoranjan Panda,Suresh Rudrapatna,Meenakshi Mallya,Harvey Rubin,Takahiro Yano,Khisi Mdluili,Christopher B. Cooper,V. Balasubramanian,Vasan K. Sambandamurthy,Vasanthi Ramachandran,Radha Shandil,Stefan Kavanagh,Shridhar Narayanan,Pravin Iyer,Kakoli Mukherjee,Vinayak P. Hosagrahara,Suresh Solapure,Shahul Hameed P,Sudha Ravishankar
MedChemComm.2016;7(5)1022
[DOI]
67Constraints of Drug Resistance in Mycobacterium tuberculosis - Prospects for Pharmacological Reversion of Susceptibility to Antibiotics
Aleksandr I. Ilin,Murat E. Kulmanov,Ilya S. Korotetskiy,Marina V. Lankina,Gulshara K. Akhmetova,Sergey V. Shvidko,Oleg N. Reva
The Open Conference Proceedings Journal.2017;8(1)33
[DOI]
68Synthesis and mechanistic investigation of iron(II) complexes of isoniazid and derivatives as a redox-mediated activation strategy for anti-tuberculosis therapy
Julie Laborde,Céline Deraeve,Francisca Gilmara de Mesquita Vieira,Alix Sournia-Saquet,Lionel Rechignat,Anne Drumond Villela,Bruno Lopes Abbadi,Fernanda Souza Macchi,Kenia Pissinate,Cristiano V. Bizarro,Pablo Machado,Luiz Augusto Basso,Geneviève Pratviel,Luiz Gonzaga de França Lopes,Eduardo Henrique Silva Sousa,Vania Bernardes-Génisson
Journal of Inorganic Biochemistry.2018;179(1)71
[DOI]
69Design, synthesis and antimycobacterial activity of various 3-(4-(substitutedsulfonyl)piperazin-1-yl)benzo[d]isoxazole derivatives
Kalaga Mahalakshmi Naidu,Amaroju Suresh,Jayanty Subbalakshmi,Dharmarajan Sriram,Perumal Yogeeswari,Pallepogu Raghavaiah,Kondapalli Venkata Gowri Chandra Sekhar
European Journal of Medicinal Chemistry.2014;87(1)71
[DOI]
70Identification of novel scaffolds targeting Mycobacterium tuberculosis
Michael Dal Molin,Petra Selchow,Daniel Schäfle,Andreas Tschumi,Thomas Ryckmans,Stephan Laage-Witt,Peter Sander
Journal of Molecular Medicine.2019;97(11)1601
[DOI]
71Antitubercular metabolites from the marine-derived fungus strain Aspergillus fumigatus MF029
Zhijun Song,Yu Liu,Jieyu Gao,Jiansen Hu,Hongtao He,Shengwang Dai,Luoqiang Wang,Huanqin Dai,Lixin Zhang,Fuhang Song
Natural Product Research.2021;35(16)2647
[DOI]
72Total Synthesis and Conformational Study of Callyaerin A: Anti-Tubercular Cyclic Peptide Bearing a Rare Rigidifying (Z )-2,3- Diaminoacrylamide Moiety
Shengping Zhang,Luis M. De Leon Rodriguez,Ivanhoe K. H. Leung,Gregory M. Cook,Paul W. R. Harris,Margaret A. Brimble
Angewandte Chemie International Edition.2018;57(14)3631
[DOI]
73Scaffold-switching: An exploration of 5,6-fused bicyclic heteroaromatics systems to afford antituberculosis activity akin to the imidazo[1,2-a]pyridine-3-carboxylates
Garrett C. Moraski,Allen G. Oliver,Lowell D. Markley,Sanghyun Cho,Scott G. Franzblau,Marvin J. Miller
Bioorganic & Medicinal Chemistry Letters.2014;24(15)3493
[DOI]
74Functionalization at C2, C3, and C4 of quinolines: Discovery of water-soluble betaine dyes of C3 quinolinium derivatives with solvatochromic and pH-sensitive properties
Sasithorn Sangher,Chatchai Kesornpun,Thammarat Aree,Chulabhorn Mahidol,Somsak Ruchirawat,Prasat Kittakoop
Dyes and Pigments.2020;178(15)108341
[DOI]
75Exploring disordered loops in DprE1 provides a functional site to combat drug-resistance in Mycobacterium strains
Jiyuan Liu,Huanqin Dai,Bo Wang,Hongwei Liu,Zhen Tian,Yalin Zhang
European Journal of Medicinal Chemistry.2022;227(15)113932
[DOI]
76Structural simplification: an efficient strategy in lead optimization
Shengzheng Wang,Guoqiang Dong,Chunquan Sheng
Acta Pharmaceutica Sinica B.2019;9(5)880
[DOI]
77Complete Genome Sequence of Multidrug-Resistant Clinical Isolate Mycobacterium tuberculosis 187.0, Used To Study the Effect of Drug Susceptibility Reversion by the New Medicinal Drug FS-1
Aleksandr I. Ilin,Murat E. Kulmanov,Ilya S. Korotetskiy,Gulshara K. Akhmetova,Marina V. Lankina,Sergey V. Shvidko,Oleg N. Reva
Genome Announcements.2015;3(6)880
[DOI]
78Challenging the Drug-Likeness Dogma for New Drug Discovery in Tuberculosis
Diana Machado,Miriam Girardini,Miguel Viveiros,Marco Pieroni
Frontiers in Microbiology.2018;9(6)880
[DOI]
79Synthesis of novel 1,2,3-triazole derivatives of isoniazid and their in vitro and in vivo antimycobacterial activity evaluation
Deepak Kumar,Deepak Beena,Garima Khare,Saqib Kidwai,Anil K. Tyagi,Ramandeep Singh,Diwan S. Rawat
European Journal of Medicinal Chemistry.2014;81(6)301
[DOI]
80Bedaquiline susceptibility test for totally drug-resistant tuberculosis Mycobacterium tuberculosis
Ji-Chan Jang,Yong-Gyun Jung,Jungil Choi,Hyunju Jung,Sungweon Ryoo
Journal of Microbiology.2017;55(6)483
[DOI]
81Bedaquiline susceptibility test for totally drug-resistant tuberculosis Mycobacterium tuberculosis
Chanchal Kumar,Kamal Shrivastava,Shraddha Gupta,Mandira Varma-Basil
Journal of Microbiology.2019;55(6)33
[DOI]
82Bedaquiline inhibits the yeast and human mitochondrial ATP synthases
Min Luo,Wenchang Zhou,Hiral Patel,Anurag P. Srivastava,Jindrich Symersky,Michal M. Bonar,José D. Faraldo-Gómez,Maofu Liao,David M. Mueller
Communications Biology.2020;3(1)33
[DOI]
83Azaaurones as Potent Antimycobacterial Agents Active against MDR- and XDR-TB
André Campaniço,Marta P. Carrasco,Mathew Njoroge,Ronnett Seldon,Kelly Chibale,João Perdigão,Isabel Portugal,Digby F. Warner,Rui Moreira,Francisca Lopes
ChemMedChem.2019;14(16)1537
[DOI]
84Genetic variants and their association with phenotypic resistance to bedaquiline in Mycobacterium tuberculosis: a systematic review and individual isolate data analysis
Nabila Ismail,Emmanuel Rivière,Jason Limberis,Stella Huo,John Z Metcalfe,Rob M Warren,Annelies Van Rie
The Lancet Microbe.2021;2(11)e604
[DOI]
85The Prospect of Repurposing Immunomodulatory Drugs for Adjunctive Chemotherapy against Tuberculosis: A Critical Review
Chiyun Lee,Sanjib Bhakta
Antibiotics.2021;10(1)91
[DOI]
86Structural insights of PA-824 derivatives: ligand-based 3D-QSAR study and design of novel PA824 derivatives as anti-tubercular agents
Bharathkumar Inturi,Gurubasavaraj V. Pujar,Madhusudhan N. Purohit
Journal of Receptors and Signal Transduction.2015;35(5)468
[DOI]
87In Silico Strategies in Tuberculosis Drug Discovery
Stephani Joy Y. Macalino,Junie B. Billones,Voltaire G. Organo,Maria Constancia O. Carrillo
Molecules.2020;25(3)665
[DOI]
88Pyridine and nitro-phenyl linked 1,3,4-thiadiazoles as MDR-TB inhibitors
Harun Patel,Harsha Jadhav,Iqrar Ansari,Rahul Pawara,Sanjay Surana
European Journal of Medicinal Chemistry.2019;167(3)1
[DOI]
89Synthesis and Study of New Quinolineaminoethanols as Anti-Bacterial Drugs
Sanjay Laumaillé,Sanjay Dassonville-Klimpt,Sanjay Peltier,Sanjay Mullié,Sanjay Andréjak,Sanjay Da-Nascimento,Sanjay Castelain,Sanjay Sonnet
Pharmaceuticals.2019;12(2)91
[DOI]
90Microbial Resistance Movements: An Overview of Global Public Health Threats Posed by Antimicrobial Resistance, and How Best to Counter
Sameer Dhingra,Nor Azlina A. Rahman,Ed Peile,Motiur Rahman,Massimo Sartelli,Mohamed Azmi Hassali,Tariqul Islam,Salequl Islam,Mainul Haque
Frontiers in Public Health.2020;8(2)91
[DOI]
91Tuberculosis: current scenario, drug targets, and future prospects
Priyanka Bose,Amit K. Harit,Ratnesh Das,Samaresh Sau,Arun K. Iyer,Sushil K. Kashaw
Medicinal Chemistry Research.2021;30(4)807
[DOI]
92Assessment of preclinical drug interactions of bedaquiline by a highly sensitive LC-ESI-MS/MS based bioanalytical method
Pankul Kotwal,Asmita Magotra,Ashish Dogra,Sumit Sharma,Abhishek Gour,Shipra Bhatt,Priya Wazir,Parvinder Pal Singh,Gurdarshan Singh,Utpal Nandi
Journal of Chromatography B.2019;1112(4)48
[DOI]
93Repurposed drug candidates for antituberculosis therapy
Qi An,Chungen Li,Yao Chen,Yong Deng,Tao Yang,Youfu Luo
European Journal of Medicinal Chemistry.2020;192(4)112175
[DOI]
94Rational design of isonicotinic acid hydrazide derivatives with antitubercular activity: Machine learning, molecular docking, synthesis and biological testing
Vasyl Kovalishyn,Julie Grouleff,Ivan Semenyuta,Vitaliy O. Sinenko,Sergiy R. Slivchuk,Diana Hodyna,Volodymyr Brovarets,Volodymyr Blagodatny,Gennady Poda,Igor V. Tetko,Larysa Metelytsia
Chemical Biology & Drug Design.2018;92(1)1272
[DOI]
95Structure, Dynamics, and Interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 Examined by Molecular Modeling, Simulation, and Electrostatic Studies
Isha Bhutani,Saurabh Loharch,Pawan Gupta,Rethi Madathil,Raman Parkesh,Chandra Verma
PLOS ONE.2015;10(3)e0119771
[DOI]
96Multiple acyl-CoA dehydrogenase deficiency kills Mycobacterium tuberculosis in vitro and during infection
Tiago Beites,Robert S. Jansen,Ruojun Wang,Adrian Jinich,Kyu Y. Rhee,Dirk Schnappinger,Sabine Ehrt
Nature Communications.2021;12(1)e0119771
[DOI]
97Identification of a novel class of quinoline–oxadiazole hybrids as anti-tuberculosis agents
Puneet P. Jain,Mariam S. Degani,Archana Raju,Aarti Anantram,Madhav Seervi,Sadhana Sathaye,Muktikanta Ray,M.G.R. Rajan
Bioorganic & Medicinal Chemistry Letters.2016;26(2)645
[DOI]
98Identification of a novel class of quinoline–oxadiazole hybrids as anti-tuberculosis agents
Célia Faustino,Joana M. Andrade,Inês M. Ferreira,Joana F. Almeida,Patrícia Rijo
Bioorganic & Medicinal Chemistry Letters.2020;65(2)41
[DOI]
99In Vitro Susceptibility Testing of Bedaquiline against Mycobacterium abscessus Complex
Barbara A. Brown-Elliott,Richard J. Wallace
Antimicrobial Agents and Chemotherapy.2019;63(2)41
[DOI]
100Bedaquiline and delamanid in tuberculosis
Susanna Esposito,Sonia Bianchini,Francesco Blasi
Expert Opinion on Pharmacotherapy.2015;16(15)2319
[DOI]
101Pretomanid: A novel therapeutic paradigm for treatment of drug resistant tuberculosis
Uzma Parveen,Safura Sultana,Salva Fatima Heba,Rehab Rafi,Aisha Begum,Nausheen Fatima
Indian Journal of Tuberculosis.2021;68(1)106
[DOI]
102Essential Medicinal Chemistry of Essential Medicines
Marta Serafini,Sarah Cargnin,Alberto Massarotti,Tracey Pirali,Armando A. Genazzani
Journal of Medicinal Chemistry.2020;63(18)10170
[DOI]
103Destination of aminoglycoside antibiotics in the ‘post-antibiotic era’
Yoshiaki Takahashi,Masayuki Igarashi
The Journal of Antibiotics.2018;71(1)4
[DOI]
104Tuberculosis: An Overview of the Immunogenic Response, Disease Progression, and Medicinal Chemistry Efforts in the Last Decade toward the Development of Potential Drugs for Extensively Drug-Resistant Tuberculosis Strains
Akanksha Sharma,Maria De Rosa,Neha Singla,Gurpal Singh,Ravi P. Barnwal,Ankur Pandey
Journal of Medicinal Chemistry.2021;64(8)4359
[DOI]
105Review of advances in diagnosis and treatment of pulmonary tuberculosis
Manjit Sharad Tendolkar,Rahul Tyagi,Ajay Handa
Indian Journal of Tuberculosis.2021;68(4)510
[DOI]
106Trends in discovery of new drugs for tuberculosis therapy
Giovanna Riccardi,Maria Rosalia Pasca
The Journal of Antibiotics.2014;67(9)655
[DOI]
107Trends in the discovery of new drugs for Mycobacterium tuberculosis therapy with a glance at resistance
Vahid Lohrasbi,Malihe Talebi,Abed Zahedi Bialvaei,Lanfranco Fattorini,Michel Drancourt,Mohsen Heidary,Davood Darban-Sarokhalil
Tuberculosis.2018;109(9)17
[DOI]
108Smart Safety Surveillance (3S): Multi-Country Experience of Implementing the 3S Concepts and Principles
Noha Iessa,Viola Macolic Sarinic,Lilit Ghazaryan,Naira Romanova,Asnakech Alemu,Watcharee Rungapiromnan,Porntip Jiamsuchon,Pattreya Pokhagul,Jose Luis Castro,Diego Macias Saint-Gerons,Gayane Ghukasyan,Mengistab Teferi,Madhur Gupta,Shanthi Narayan Pal
Drug Safety.2021;44(10)1085
[DOI]
109Optimizing Bedaquiline for cardiotoxicity by structure based virtual screening, DFT analysis and molecular dynamic simulation studies to identify selective MDR-TB inhibitors
Iqrar Ahmad,Harsha Jadhav,Yashodeep Shinde,Vilas Jagtap,Rukaiyya Girase,Harun Patel
In Silico Pharmacology.2021;9(1)1085
[DOI]
110Preliminary SAR and biological evaluation of antitubercular triazolothiadiazine derivatives against drug-susceptible and drug-resistant Mtb strains
Ziqiang Li,Xiaoguang Bai,Qi Deng,Guoning Zhang,Lei Zhou,Yishuang Liu,Juxian Wang,Yucheng Wang
Bioorganic & Medicinal Chemistry.2017;25(1)213
[DOI]
111A temporal proteome dynamics study reveals the molecular basis of induced phenotypic resistance in Mycobacterium smegmatis at sub-lethal rifampicin concentrations
Alexander D. Giddey,Elise de Kock,Kehilwe C. Nakedi,Shaun Garnett,Andrew J. M. Nel,Nelson C. Soares,Jonathan M. Blackburn
Scientific Reports.2017;7(1)213
[DOI]
112Synthesis, bioevaluation and molecular docking study of new piperazine and amide linked dimeric 1,2,3-triazoles
Tejshri R. Deshmukh,Smita P. Khare,Vagolu S. Krishna,Dharmarajan Sriram,Jaiprakash N. Sangshetti,Vijay M. Khedkar,Bapurao B. Shingate
Synthetic Communications.2020;50(2)271
[DOI]
113Long-term impact of the adoption of bedaquiline-containing regimens on the burden of drug-resistant tuberculosis in China
Abela Mpobela Agnarson,Xiao Chun Wang,Ravi Potluri,Hitesh Bhandari,Amit Dhir,Chrispin Kambili,Laurent Metz
BMC Infectious Diseases.2020;20(1)271
[DOI]
114Controlling strategy of dormant Mycobacterium tuberculosis
Gan Yiling,Guo Shuliang
Chinese Medical Journal.2014;127(18)3316
[DOI]
115Selective drug deposition in lungs through pulmonary drug delivery system for effective management of drug-resistant TB
Kaksha Sankhe,Tabassum Khan,Chintan Bhavsar,Munira Momin,Abdelwahab Omri
Expert Opinion on Drug Delivery.2019;16(5)525
[DOI]
116Intracellular and in vivo evaluation of imidazo[2,1-b]thiazole-5-carboxamide anti-tuberculosis compounds
Garrett C. Moraski,Nathalie Deboosère,Kate L. Marshall,Heath A. Weaver,Alexandre Vandeputte,Courtney Hastings,Lisa Woolhiser,Anne J. Lenaerts,Priscille Brodin,Marvin J. Miller,Olivier Neyrolles
PLOS ONE.2020;15(1)e0227224
[DOI]
117Short-course treatment for multidrug-resistant tuberculosis: the STREAM trials
Riya Moodley,Thomas R. Godec
European Respiratory Review.2016;25(139)29
[DOI]
118Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design
Marco Pieroni,Baojie Wan,Valentina Zuliani,Scott G. Franzblau,Gabriele Costantino,Mirko Rivara
European Journal of Medicinal Chemistry.2015;100(139)44
[DOI]
119Synthesis, oxidation potential and anti-mycobacterial activity of isoniazid and analogues: insights into the molecular isoniazid activation mechanism
Julie Laborde,Céline Deraeve,Léa Lecoq,Alix Sournia-Saquet,Jean-Luc Stigliani,Beatrice S. Orena,Giorgia Mori,Geneviève Pratviel,Vania Bernardes-Génisson
ChemistrySelect.2016;1(2)172
[DOI]
120Synthesis, oxidation potential and anti-mycobacterial activity of isoniazid and analogues: insights into the molecular isoniazid activation mechanism
Marco Pieroni
ChemistrySelect.2019;52(2)27
[DOI]
121Discovery of in vitro antitubercular agents through in silico ligand-based approaches
Daniela De Vita,Fabiana Pandolfi,Roberto Cirilli,Luigi Scipione,Roberto Di Santo,Laura Friggeri,Mattia Mori,Diego Fiorucci,Giorgio Maccari,Robert Selwyne Arul Christopher,Claudio Zamperini,Valentina Pau,Alessandro De Logu,Silvano Tortorella,Maurizio Botta
European Journal of Medicinal Chemistry.2016;121(2)169
[DOI]
122High-Content Screening of Raw Actinomycete Extracts for the Identification of Antituberculosis Activities
Jinyeong Heo,Jiyoun Nam,Jichan Jang,David Shum,Constantin Radu,Jinhua Cheng,Hanki Lee,Joo-Won Suh,Vincent Delorme
SLAS DISCOVERY: Advancing the Science of Drug Discovery.2017;22(2)144
[DOI]
123What are the origins of growing microbial resistance? Both Lamarck and Darwin were right
Juan Alberto Guevara Salazar,Jessica Rubí Morán Díaz,Enrique Ramírez Segura,José Guadalupe Trujillo Ferrara
Expert Review of Anti-infective Therapy.2021;19(5)563
[DOI]
124Alkylated/aminated nitroimidazoles and nitroimidazole-7-chloroquinoline conjugates: Synthesis and anti-mycobacterial evaluation
José Guadalupe Shalini,Albertus Viljoen,Laurent Kremer,Vipan Kumar
Bioorganic & Medicinal Chemistry Letters.2018;28(8)1309
[DOI]
125Bedaquiline: Current status and future perspectives
Saeed Khoshnood,Mehdi Goudarzi,Elahe Taki,Atieh Darbandi,Ebrahim Kouhsari,Mohsen Heidary,Moloudsadat Motahar,Melika Moradi,Hadi Bazyar
Journal of Global Antimicrobial Resistance.2021;25(8)48
[DOI]
126Synthesis, Characterization, Molecular Docking Studies and Biological Evaluation of Some Conjugated Quinazoline-Sulfonamide Scaffold
A. Sunil Kumar,Jyothi Kudva,B. R. Bharath,Vaishali M Rai,S. Madan Kumar,Vasantha Kumar,Shyama Prasad Sajankila
ChemistrySelect.2018;3(48)13586
[DOI]
127TBAJ-876, a 3,5-Dialkoxypyridine Analogue of Bedaquiline, Is Active against Mycobacterium abscessus
Jickky Palmae Sarathy,Uday S. Ganapathy,Matthew D. Zimmerman,Véronique Dartois,Martin Gengenbacher,Thomas Dick
Antimicrobial Agents and Chemotherapy.2020;64(4)13586
[DOI]
128Primary Bedaquiline Resistance Among Cases of Drug-Resistant Tuberculosis in Taiwan
Sheng-Han Wu,Hsin-Hua Chan,Hseuh-Chien Hsiao,Ruwen Jou
Frontiers in Microbiology.2021;12(4)13586
[DOI]
129Synergistic Response of Rifampicin with Hydroperoxides on Mycobacterium: A Mechanistic Study
Yesha S. Patel,Sarika Mehra
Frontiers in Microbiology.2017;8(4)13586
[DOI]
  Feedback 
  Subscribe 

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal